Report Cover

Global Peripheral Intervention Drug-Eluting Devices Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026


The Peripheral Intervention Drug-Eluting Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Peripheral Intervention Drug-Eluting Devices size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Peripheral Intervention Drug-Eluting Devices market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Peripheral Intervention Drug-Eluting Devices market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Plain Old Balloon Angioplasty (POBA)
    Percutaneous Transluminal Angioplasty (PTA)

Market segment by Application can be divided into
    Drug-Eluting Balloons
    Drug-Eluting Stents

The key market players for global Peripheral Intervention Drug-Eluting Devices market are listed below:
    Medtronic plc
    Boston Scientific Corporation
    Abbott Laboratories
    Cardinal Health
    B. Braun Melsungen AG
    Biosensors International Group Ltd.
    C.R. Bard, Inc.
    Abbott
    The Lubrizol Corporation
    Terumo Corporation

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
    1.1 Peripheral Intervention Drug-Eluting Devices Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Peripheral Intervention Drug-Eluting Devices Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Plain Old Balloon Angioplasty (POBA)
        1.2.3 Percutaneous Transluminal Angioplasty (PTA)
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Peripheral Intervention Drug-Eluting Devices Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Drug-Eluting Balloons
        1.3.3 Drug-Eluting Stents
    1.4 Global Peripheral Intervention Drug-Eluting Devices Market Size & Forecast
        1.4.1 Global Peripheral Intervention Drug-Eluting Devices Sales in Value (2016-2026))
        1.4.2 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume (2016-2026)
        1.4.3 Global Peripheral Intervention Drug-Eluting Devices Price by Type (2016-2026) & (USD/Unit)
    1.5 Global Peripheral Intervention Drug-Eluting Devices Production Capacity Analysis
        1.5.1 Global Peripheral Intervention Drug-Eluting Devices Total Production Capacity (2016-2026)
        1.5.2 Global Peripheral Intervention Drug-Eluting Devices Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Peripheral Intervention Drug-Eluting Devices Market Drivers
        1.6.2 Peripheral Intervention Drug-Eluting Devices Market Restraints
        1.6.3 Peripheral Intervention Drug-Eluting Devices Trends Analysis
2 Manufacturers Profiles
    2.1 Medtronic plc
        2.1.1 Medtronic plc Details
        2.1.2 Medtronic plc Major Business
        2.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Product and Services
        2.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.2 Boston Scientific Corporation
        2.2.1 Boston Scientific Corporation Details
        2.2.2 Boston Scientific Corporation Major Business
        2.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
        2.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.3 Abbott Laboratories
        2.3.1 Abbott Laboratories Details
        2.3.2 Abbott Laboratories Major Business
        2.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product and Services
        2.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.4 Cardinal Health
        2.4.1 Cardinal Health Details
        2.4.2 Cardinal Health Major Business
        2.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Product and Services
        2.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.5 B. Braun Melsungen AG
        2.5.1 B. Braun Melsungen AG Details
        2.5.2 B. Braun Melsungen AG Major Business
        2.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product and Services
        2.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.6 Biosensors International Group Ltd.
        2.6.1 Biosensors International Group Ltd. Details
        2.6.2 Biosensors International Group Ltd. Major Business
        2.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product and Services
        2.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.7 C.R. Bard, Inc.
        2.7.1 C.R. Bard, Inc. Details
        2.7.2 C.R. Bard, Inc. Major Business
        2.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product and Services
        2.7.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.8 Abbott
        2.8.1 Abbott Details
        2.8.2 Abbott Major Business
        2.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Product and Services
        2.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.9 The Lubrizol Corporation
        2.9.1 The Lubrizol Corporation Details
        2.9.2 The Lubrizol Corporation Major Business
        2.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
        2.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.10 Terumo Corporation
        2.10.1 Terumo Corporation Details
        2.10.2 Terumo Corporation Major Business
        2.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
        2.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Peripheral Intervention Drug-Eluting Devices Sales by Manufacturer
    3.1 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Peripheral Intervention Drug-Eluting Devices
    3.4 Market Concentration Rate
        3.4.1 Top 3 Peripheral Intervention Drug-Eluting Devices Manufacturer Market Share
        3.4.2 Top 6 Peripheral Intervention Drug-Eluting Devices Manufacturer Market Share
    3.5 Global Peripheral Intervention Drug-Eluting Devices Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Peripheral Intervention Drug-Eluting Devices Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Region
        4.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume by Region (2016-2026)
        4.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Region (2016-2026)
    4.2 North America Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026)
    4.3 Europe Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026)
    4.4 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026)
    4.5 South America Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026)
    4.6 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026)
5 Market Segment by Type
    5.1 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume by Type (2016-2026)
    5.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2016-2026)
    5.3 Global Peripheral Intervention Drug-Eluting Devices Price by Type (2016-2026)
6 Market Segment by Application
    6.1 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume by Application (2016-2026)
    6.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2016-2026)
    6.3 Global Peripheral Intervention Drug-Eluting Devices Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
    7.1 North America Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2026)
    7.2 North America Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2026)
    7.3 North America Peripheral Intervention Drug-Eluting Devices Market Size by Country
        7.3.1 North America Peripheral Intervention Drug-Eluting Devices Sales in Volume by Country (2016-2026)
        7.3.2 North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
    8.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2026)
    8.2 Europe Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2026)
    8.3 Europe Peripheral Intervention Drug-Eluting Devices Market Size by Country
        8.3.1 Europe Peripheral Intervention Drug-Eluting Devices Sales in Volume by Country (2016-2026)
        8.3.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2026)
    9.2 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2026)
    9.3 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Size by Region
        9.3.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
    10.1 South America Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2026)
    10.2 South America Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2026)
    10.3 South America Peripheral Intervention Drug-Eluting Devices Market Size by Country
        10.3.1 South America Peripheral Intervention Drug-Eluting Devices Sales in Volume by Country (2016-2026)
        10.3.2 South America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2026)
    11.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2026)
    11.3 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Market Size by Country
        11.3.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Peripheral Intervention Drug-Eluting Devices Typical Distributors
    12.3 Peripheral Intervention Drug-Eluting Devices Typical Customers
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

List of Tables Table 1. Global Peripheral Intervention Drug-Eluting Devices Revenue by Type, (USD Million), 2021-2026 Table 2. Global Peripheral Intervention Drug-Eluting Devices Revenue by Application, (USD Million), 2021-2026 Table 3. Medtronic plc Basic Information, Manufacturing Base and Competitors Table 4. Medtronic plc Major Business Table 5. Medtronic plc Peripheral Intervention Drug-Eluting Devices Product and Services Table 6. Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 7. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors Table 8. Boston Scientific Corporation Major Business Table 9. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product and Services Table 10. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 11. Abbott Laboratories Basic Information, Manufacturing Base and Competitors Table 12. Abbott Laboratories Major Business Table 13. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product and Services Table 14. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 15. Cardinal Health Basic Information, Manufacturing Base and Competitors Table 16. Cardinal Health Major Business Table 17. Cardinal Health Peripheral Intervention Drug-Eluting Devices Product and Services Table 18. Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 19. B. Braun Melsungen AG Basic Information, Manufacturing Base and Competitors Table 20. B. Braun Melsungen AG Major Business Table 21. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product and Services Table 22. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 23. Biosensors International Group Ltd. Basic Information, Manufacturing Base and Competitors Table 24. Biosensors International Group Ltd. Major Business Table 25. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product and Services Table 26. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 27. C.R. Bard, Inc. Basic Information, Manufacturing Base and Competitors Table 28. C.R. Bard, Inc. Major Business Table 29. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product and Services Table 30. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 31. Abbott Basic Information, Manufacturing Base and Competitors Table 32. Abbott Major Business Table 33. Abbott Peripheral Intervention Drug-Eluting Devices Product and Services Table 34. Abbott Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 35. The Lubrizol Corporation Basic Information, Manufacturing Base and Competitors Table 36. The Lubrizol Corporation Major Business Table 37. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product and Services Table 38. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 39. Terumo Corporation Basic Information, Manufacturing Base and Competitors Table 40. Terumo Corporation Major Business Table 41. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product and Services Table 42. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 43. Global Peripheral Intervention Drug-Eluting Devices Sales by Manufacturer (2019-2021e) & (K Units) Table 44. Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer (2019-2021e) & (USD Million) Table 45. Market Position of Manufacturers in Peripheral Intervention Drug-Eluting Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020 Table 46. Global Peripheral Intervention Drug-Eluting Devices Production Capacity by Company, (K Units): 2020 VS 2021 Table 47. Head Office and Peripheral Intervention Drug-Eluting Devices Production Site of Key Manufacturer Table 48. Global Peripheral Intervention Drug-Eluting Devices Sales by Region (2016-2021e) & (K Units) Table 49. Global Peripheral Intervention Drug-Eluting Devices Sales by Region (2021-2026) & (K Units) Table 50. Global Peripheral Intervention Drug-Eluting Devices Revenue by Region (2016-2021e) & (USD Million) Table 51. Global Peripheral Intervention Drug-Eluting Devices Revenue by Region (2021-2026) & (USD Million) Table 52. Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units) Table 53. Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2021-2026) & (K Units) Table 54. Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2016-2021e) & (USD Million) Table 55. Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2021-2026) & (USD Million) Table 56. Global Peripheral Intervention Drug-Eluting Devices Price by Type (2016-2021e) & (USD/Unit) Table 57. Global Peripheral Intervention Drug-Eluting Devices Price by Type (2021-2026) & (USD/Unit) Table 58. Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units) Table 59. Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2021-2026) & (K Units) Table 60. Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2016-2021e) & (USD Million) Table 61. Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2021-2026) & (USD Million) Table 62. Global Peripheral Intervention Drug-Eluting Devices Price by Application (2016-2021e) & (USD/Unit) Table 63. Global Peripheral Intervention Drug-Eluting Devices Price by Application (2021-2026) & (USD/Unit) Table 64. North America Peripheral Intervention Drug-Eluting Devices Sales by Country (2016-2021e) & (K Units) Table 65. North America Peripheral Intervention Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 66. North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2021e) & (USD Million) Table 67. North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2021-2026) & (USD Million) Table 68. North America Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units) Table 69. North America Peripheral Intervention Drug-Eluting Devices Sales by Type (2021-2026) & (K Units) Table 70. North America Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units) Table 71. North America Peripheral Intervention Drug-Eluting Devices Sales by Application (2021-2026) & (K Units) Table 72. Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2016-2021e) & (K Units) Table 73. Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 74. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2021e) & (USD Million) Table 75. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2021-2026) & (USD Million) Table 76. Europe Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units) Table 77. Europe Peripheral Intervention Drug-Eluting Devices Sales by Type (2021-2026) & (K Units) Table 78. Europe Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units) Table 79. Europe Peripheral Intervention Drug-Eluting Devices Sales by Application (2021-2026) & (K Units) Table 80. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Region (2016-2021e) & (K Units) Table 81. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Region (2021-2026) & (K Units) Table 82. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region (2016-2021e) & (USD Million) Table 83. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region (2021-2026) & (USD Million) Table 84. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units) Table 85. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Type (2021-2026) & (K Units) Table 86. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units) Table 87. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Application (2021-2026) & (K Units) Table 88. South America Peripheral Intervention Drug-Eluting Devices Sales by Country (2016-2021e) & (K Units) Table 89. South America Peripheral Intervention Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 90. South America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2021e) & (USD Million) Table 91. South America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2021-2026) & (USD Million) Table 92. South America Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units) Table 93. South America Peripheral Intervention Drug-Eluting Devices Sales by Type (2021-2026) & (K Units) Table 94. South America Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units) Table 95. South America Peripheral Intervention Drug-Eluting Devices Sales by Application (2021-2026) & (K Units) Table 96. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2016-2021e) & (K Units) Table 97. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 98. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2016-2021e) & (USD Million) Table 99. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2021-2026) & (USD Million) Table 100. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units) Table 101. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Type (2021-2026) & (K Units) Table 102. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units) Table 103. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Application (2021-2026) & (K Units) Table 104. Direct Channel Pros & Cons Table 105. Indirect Channel Pros & Cons Table 106. Peripheral Intervention Drug-Eluting Devices Typical Distributors Table 107. Peripheral Intervention Drug-Eluting Devices Typical Customers List of Figures Figure 1. Peripheral Intervention Drug-Eluting Devices Picture Figure 2. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2020 Figure 3. Plain Old Balloon Angioplasty (POBA) Figure 4. Percutaneous Transluminal Angioplasty (PTA) Figure 5. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application in 2020 Figure 6. Drug-Eluting Balloons Figure 7. Drug-Eluting Stents Figure 8. Global Peripheral Intervention Drug-Eluting Devices Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026 Figure 9. Global Peripheral Intervention Drug-Eluting Devices Market Size and Forecast (2016-2026) & (USD Million) Figure 10. United States Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 11. Canada Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 12. Mexico Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 13. Germany Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 14. France Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 15. United Kingdom Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 16. Russia Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 17. Italy Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 18. China Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 19. Japan Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 20. Korea Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 21. India Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 22. Southeast Asia Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 23. Australia Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 24. Brazil Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 25. Egypt Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 26. Saudi Arabia Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 27. South Africa Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 28. Turkey Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million) Figure 29. Global Peripheral Intervention Drug-Eluting Devices Sales (2016-2026) & (K Units) Figure 30. Global Peripheral Intervention Drug-Eluting Devices Production Capacity (2016-2026) & (K Units) Figure 31. Global Peripheral Intervention Drug-Eluting Devices Production Capacity by Geographic Region: 2020 VS 2021 Figure 32. Peripheral Intervention Drug-Eluting Devices Market Drivers Figure 33. Peripheral Intervention Drug-Eluting Devices Market Restraints Figure 34. Peripheral Intervention Drug-Eluting Devices Market Trends Figure 35. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturer in 2020 Figure 36. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturer in 2020 Figure 37. Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3) Figure 38. Top 3 Peripheral Intervention Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2020 Figure 39. Top 6 Peripheral Intervention Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2020 Figure 40. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2016-2026) Figure 41. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2016-2026) Figure 42. North America Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026) & (USD Million) Figure 43. Europe Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026) & (USD Million) Figure 44. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026) & (USD Million) Figure 45. South America Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026) & (USD Million) Figure 46. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue (2016-2026) & (USD Million) Figure 47. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2026) Figure 48. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2016-2026) Figure 49. Global Peripheral Intervention Drug-Eluting Devices Price by Type (2016-2026) & (USD/Unit) Figure 50. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2026) Figure 51. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2016-2026) Figure 52. Global Peripheral Intervention Drug-Eluting Devices Price by Application (2016-2026) & (USD/Unit) Figure 53. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2016-2026) Figure 54. North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2016-2026) Figure 55. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2026) Figure 56. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2026) Figure 57. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2016-2026) Figure 58. Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2016-2026) Figure 59. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2026) Figure 60. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2026) Figure 61. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2016-2026) Figure 62. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2016-2026) Figure 63. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2016-2026) Figure 64. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2026) Figure 65. South America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2016-2026) Figure 66. South America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2016-2026) Figure 67. South America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2026) Figure 68. South America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2026) Figure 69. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2016-2026) Figure 70. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2016-2026) Figure 71. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2026) Figure 72. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2026) Figure 73. Sales Channel: Direct Channel vs Indirect Channel Figure 74. Methodology Figure 75. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us